News

Cadence (NASDAQ: CDNS) and Synopsys (NASDAQ: SNPS) are the two dominant players in Electronic Design Automation, selling the proprietary toolchains, Cadence’s Genus, Innovus, and Virtuoso; Synopsys’s Design Compiler and IC Compiler, that chipmakers rely on to design, simulate, and verify semiconductors. The bull case for both stocks rests on the assumption that surging AI chip complexity will drive ever-greater demand for those licensed tools. Kimi K3’s demonstration that a frontier AI model can

A critical chip design stock has fallen back to a floor it has defended six times before, forcing investors to decide if history is a guide or a trap.

The latest trading day saw Synopsys (SNPS) settling at $417.03, representing a -1.94% change from its previous close.

Investors who like buying dips may want to start with these three AI stocks.

Arm Holdings' expanding royalty opportunities and AI-focused chip strategy are strengthening its long-term growth potential.

Investing.com -- Benchmark initiated coverage of electronic design automation (EDA) software leaders Synopsys and Cadence Design Systems with Buy ratings, citing strong long-term demand driven by artificial intelligence, semiconductor design complexity and resilient industry fundamentals.

SpaceX initiated, Lululemon downgraded: Wall Street's top analyst calls

Synopsys (SNPS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

The software giant looks expensive on the surface, but a two-year view reveals a valuation story that is far more grounded.

Synopsys, Inc. (NASDAQ:SNPS) is one of the high-growth wide-moat stocks to buy. On July 7, Reuters reported that Synopsys plans to discontinue selected semiconductor manufacturing analytics products, including tools used to monitor production anomalies, while reallocating resources toward higher-margin chip-design and AI-design offerings. The company said the products being retired were legacy diagnostic tools outside […]

A critical piece of the AI supply chain has fallen back to a price floor it has defended nine times before, forcing investors to ask if the tenth test will be the one that breaks.

Cadence leads in 2nm partnerships while Synopsys scales broader capabilities, but their financial profiles and risk exposures diverge sharply.

Synopsys powers every AI chip on the planet yet trades nearly 20% below where it stood a year ago, which raises a question Wall Street has not fully answered: how far can this stock run before 2030?

On 27 June 2026, Synopsys, Inc. was removed from several Russell indices, including the Russell 1000 Growth, 3000 Growth, and Top 200 Growth benchmarks, reflecting a broad reshuffle of these equity baskets. This wave of index exclusions matters because it can alter how many passive and benchmark-tracking funds hold Synopsys, potentially changing the stock’s trading profile and liquidity over time. With Synopsys now dropped from multiple Russell indices, we’ll examine how this index reshaping...

Synopsys stock sits at an interesting valuation crossroads, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to roughly 10.4% upside while traditional market multiples suggest the shares are priced on the rich side. That split comes after the stock has delivered a 59.7% gain over five years, even though the shorter term picture has been weaker. Over the past five years Synopsys has returned 59.7%, which means long term holders have still come out ahead despite the more...

What Synopsys Investors Can Take From The Russell Index Removals Synopsys (SNPS) was recently removed from several Russell indexes, including the Russell 1000 Growth Benchmark and Russell 1000 Defensive Index. This is a technical shift that can influence how certain institutional investors gain exposure to the stock. See our latest analysis for Synopsys. Over the past year, Synopsys has seen its share price move around, with a 1 day share price return of 2.04% and a 90 day share price return...

Synopsys is walking away from older manufacturing software as it pours money into AI chip design tools

After a period of underperformance, a pivotal but often overlooked part of the company's business is showing signs of a powerful new life.

Synopsys (NASDAQ:SNPS) has become one of the most important picks-and-shovels plays on the AI buildout, yet the stock has quietly slipped 16.43% over the past year. Our 24/7 Wall St. price target for Synopsys is $516.71, implying 18.2% upside from the current $437.16 level. Our recommendation is buy, at a 90% confidence level, one of ... Synopsys Could Still Be One of the Smartest AI Stocks to Buy in 2026

Tech stocks were lower Tuesday afternoon, with the State Street Technology Select Sector SPDR ETF (X

Synopsys Inc. (NASDAQ:SNPS) is one of the top 10 AI stocks that will skyrocket. On June 17, Synopsys Inc. (NASDAQ:SNPS) revealed the launch of its first Multiphysics Fusion solutions, which bring together AI-enabled EDA solutions of Synopsys with golden signoff analysis of Ansys across multi-die design, timing signoff, design closure, and analog workflows. The company […]

A software firm is growing like a startup but priced like a utility, creating a contradiction the market cannot ignore for long.

Synopsys shifts resources away from manufacturing softwareSynopsys (NASDAQ:SNPS) is preparing to discontinue a suite of semiconductor manufacturing process control software as the company redirects investment towards higher-margin artificial intelligence design technologies, according to six sources familiar with the plans. Sources said the US chip design software company informed more than 10 semiconductor manufacturers during April and May that several manufacturing analytics products had reac

U.S. chip design giant Synopsys plans to stop offering a suite of manufacturing process control software used by global semiconductor makers, six sources briefed on the matter said, as it seeks to ‌divert resources to higher-margin offerings such as AI design. Synopsys in April and May informed more than 10 chipmakers including Samsung Electronics, ‌SK Hynix, Kioxia Holdings Corp and Qorvo Inc about the "end of life" move that means Synopsys will not provide future new versions and will only carry out maintenance obligations, two of ​the sources said.

Synopsys (SNPS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Synopsys (NASDAQ:SNPS) sits at the center of every advanced chip designed today, and the math behind our model says the market is underpricing that moat. With shares trading at $454.34, our 24/7 Wall St. price target for Synopsys is $561.65, implying 23.62% upside over the next twelve months. The recommendation is buy at a 90% ... Price Prediction: Synopsys’ Chip-Design Moat and The Path to 24% Upside

Synopsys, Inc. (NASDAQ:SNPS) is among the Best Semiconductor Stocks. On June 23, Piper Sandler upgraded Synopsys, Inc. (NASDAQ:SNPS) to “Overweight” from Neutral. The analyst raised the price target to $550 from $450 on the shares. Analyst Clarke Jeffries said the firm expects a faster-than-anticipated recovery in Synopsys’ intellectual property business. The analyst noted improving expectations for […]

Synopsys (SNPS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Synopsys’ modelled fair value has held effectively steady, edging from about US$560.38 to roughly US$559.58 per share, which keeps the price target story more about refinement than reset. That small shift comes as Street research stays broadly supportive but split between optimism on the intellectual property and Ansys pieces and caution on execution risks and valuation. As you read on, you will see how to interpret these moving parts and track the evolving Synopsys narrative with more...

The fund's big gain wasn't a tide that lifted all boats; it was a rocket powered by a handful of its holdings.